Monoclonal antibodyPhase 3 trialInvestigational
Dinutuximab beta
How it works
Binds to the GD2 antigen on cancer cells, marking them for immune destruction.
Cancer types
Colorectal Cancer— All patients
Efficacy
Clinical trials are ongoing to evaluate the efficacy and safety of dinutuximab beta in patients with metastatic colorectal cancer.
Side effects
Mild
Most people tolerate this treatment well. Side effects are generally manageable and do not require stopping treatment.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.